RFP
EBS icon

Root Financial Partners’s Emergent Biosolutions EBS Stock Holding History

Root Financial Partners’s Portfolio EBS Stock Details EBS Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$2.27K Buy
+274
New +$2.84K ﹤0.01% 2265

Other funds holding EBS

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

Root Financial Partners's EBS Position: Q1 2026 in Review

Root Financial Partners opened a new position in Emergent Biosolutions (EBS) in Q1 2026: 274 shares worth $2.27K. The stake represents ﹤0.01% of the portfolio and ranks #2265 among its holdings.

190 funds tracked by Wall St. Rank hold EBS as of Q1 2026.

  • Root Financial Partners held 274 shares of Emergent Biosolutions worth $2.27K as of Q1 2026.
  • Emergent Biosolutions was a new Root Financial Partners position in Q1 2026.
  • Emergent Biosolutions made up ﹤0.01% of Root Financial Partners's portfolio in Q1 2026, its #2265 holding.
  • 190 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q1 2026.

Based on Root Financial Partners's 13F filing for Q1 2026, filed 24 Apr 2026.